Merck logo

Associate Principal Scientist (Associate Director) Regulatory Affairs - ADC

Merck

Rahway, NJHybridPosted 2 days ago$142,400.00 - $224,100.00
Full TimeSenior LevelRegulatory AffairsPharmaceutical
Original posting ↗

Summary

This Associate Principal Scientist position is equivalent to an Associate Director position. Under the direction of a Director/Executive Director, the Associate Principal Scientist is responsible for developing and implementing Chemistry, Manufacturing, and Controls (CMC) regulatory strategies for biologic products in accordance with global regulatory requirements and guidance.

Job description

Role Overview

This Associate Principal Scientist position is equivalent to an Associate Director position. Under the direction of a Director/Executive Director, the Associate Principal Scientist is responsible for developing and implementing Chemistry, Manufacturing, and Controls (CMC) regulatory strategies for biologic products in accordance with global regulatory requirements and guidance.

The role may support ADCs and other bioconjugate modalities, requiring integrated CMC regulatory strategies across the antibody, linker-payload or other conjugated components, conjugation process, and finished drug product. Responsibilities include preparing and submitting CMC content across the product lifecycle, from early and late-stage development through registration and post-approval lifecycle management.

The Associate Principal Scientist also contributes to the development and implementation of internal regulatory strategies and provides mentoring and coaching to Scientists and Senior Scientists supporting assigned projects.

Responsibilities

  • Development and execution of detailed, global regulatory strategies for submission and approval of INDs, BLAs or post approval change documentation according to defined timelines.
  • Lead or contribute to global CMC regulatory strategy and submissions for ADCs and other bioconjugates, addressing the interfaces among the biologic starting material, synthetic or conjugated component, conjugation process, analytical control strategy, and drug product.
  • Participation in the authorization process to prioritize submissions.
  • In depth knowledge of global CMC guidelines regarding IND/BLAs or post approval changes.
  • Completion of detailed, global regulatory assessments according to existing global guidelines and policies and defined timelines.
  • Careful planning, tracking and communicating regarding submissions and approvals to support continued product supply.
  • Lead authoring of clear, concise and effective IND / CTAs, BLAs or global post approval submissions according to defined timelines.
  • Collaborate with partner groups in the authoring and reviewing process to ensure compliance, scientific excellence, accuracy and completeness of submissions.
  • Resolve project issues through collaboration with the team and escalation to the CMC leadership team as appropriate.
  • Participation in early and late development programs, as well as departmental and cross-functional efforts to improve CMC content or processes may also be required, as needed.

Education Minimum Requirement

B.S. in a science, engineering, or a related field (advanced degree preferred). Fields of study include Chemical Engineering, Biology, Microbiology, Virology, Molecular Biology, or Biochemistry.

Required Experience and Skills

  • Prior Biologics IND, License Application (BLA) and/or post approval filing experience with at least 10 years subject matter expertise in biologics CMC development or manufacturing.
  • Experience in biologics regulatory CMC in both pre-approval and registration required, with experience authoring agency interactions, responses to questions, and IND/IMPD and BLA sections.
  • Demonstrated sound understanding of related fields (e.g., manufacturing, process development, analytical, quality assurance) and the ability to be creative and imaginative in the approach to new and diverse problem solving.
  • Proven experience in critically reviewing detailed scientific information and assessing whether technical arguments are presented clearly and conclusions are adequately supported by data.
  • Demonstrated superior oral and written communication skills in multicultural settings and ability to communicate complex issues in a succinct and logical manner.
  • Demonstrated flexibility in responding to changing priorities or dealing with unexpected events.
  • Demonstrated effective leadership, project management, communication, interpersonal and negotiating skills.
  • Demonstrated ability to generate innovative solutions to complex regulatory problems and effectively work with and communicate to key stakeholders.

Preferred Experience and Skills

  • Experience with ADCs, bioconjugates, or other complex biologic modalities is preferred.
  • Experience with combination products or complex dosage forms is an additional advantage.
  • Preferred fields of study include Microbiology, Virology, Molecular Biology, Chemistry, Engineering or Biochemistry.

Requirements

  • B.S. in a science, engineering, or a related field (advanced degree preferred)
  • Prior Biologics IND, License Application (BLA) and/or post approval filing experience
  • At least 10 years subject matter expertise in biologics CMC development or manufacturing
  • Experience in biologics regulatory CMC in both pre-approval and registration
  • Experience authoring agency interactions, responses to questions, and IND/IMPD and BLA sections
  • Demonstrated sound understanding of related fields (manufacturing, process development, analytical, quality assurance)
  • Proven experience critically reviewing detailed scientific information
  • Demonstrated superior oral and written communication skills in multicultural settings
  • Demonstrated flexibility in responding to changing priorities or unexpected events
  • Demonstrated effective leadership, project management, communication, interpersonal and negotiating skills
  • Demonstrated ability to generate innovative solutions to complex regulatory problems
  • Antibody Drug Conjugates (ADC)
  • Biologics
  • Biologics License Application (BLA)
  • CMC Biologics
  • CMC Development
  • Electronic Common Technical Document (eCTD)
  • International Regulatory Compliance
  • Life Cycle Management
  • Pharmaceutical Regulatory Affairs
  • Regulatory CMC

Benefits

  • Medical, Dental & Vision
  • Other Insurance Benefits
  • 401(k) Retirement
  • Paid Holidays
  • Vacation
  • Compassionate & Sick Days
  • Annual Bonus
  • Long-Term Incentive

Company overview

Merck & Co., Inc., known as Merck in the United States and Canada and MSD (Merck Sharp & Dohme) internationally, is a premier American multinational pharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891 as the U.S. subsidiary of the German Merck Group, the company became independent following World War I and has since grown into one of the world's largest biomedical companies, ranking fourth globally by revenue. Merck operates across three core business segments: pharmaceuticals, vaccines, and animal health products. The company is renowned for its groundbreaking research and development, having brought numerous life-saving medicines to market including Keytruda (pembrolizumab), a leading immunotherapy for cancer treatment that generated $29.5 billion in 2024 revenue, and Gardasil, a revolutionary HPV vaccine. With approximately 75,000 employees worldwide, Merck maintains a robust pipeline of innovative therapies focused on oncology, vaccines, hospital acute care, cardiology, neuroscience, virology, immunology, and diabetes. The company invests heavily in R&D, spending $17.9 billion in 2024 alone, demonstrating its commitment to advancing scientific discovery. Merck's legacy spans over 130 years of bringing hope to humanity through important medicines and vaccines, operating with a purpose to use leading-edge science to save and improve lives globally while fostering an inclusive workforce and responsible business practices.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.